CRNX vs SYK · rev $7.7M vs P/E 35, rev $6.59B
Crinetics Pharmaceuticals Inc (CRNX) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. CRNX currently screens at market cap $2.76B.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
CRNX currently screens at market cap $2.76B. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the CRNX and SYK stock pages for the full models.
Not investment advice.